CHICAGO, Oct. 15, 2024 (GLOBE NEWSWIRE) — Mondelēz International, Inc. (Nasdaq: MDLZ) will release its third quarter 2024 financial results on Tuesday, October 29, 2024 at 4:05 p.m. ET and will host a conference call at 5:00 p.m. ET that day.
Investors and analysts may participate via phone by calling 800-225-9448 from the United States and 203-518-9708 from other locations. To ensure timely access, participants should dial in approximately 10 minutes before the call starts. A listen-only webcast will be provided at www.mondelezinternational.com.
A replay of the conference call will be available until November 5, 2024, by calling 800-839-1247 from the United States and 402-220-0470 from other locations. The access code for both the conference call and its rebroadcast is MDLZQ324. An archive of the webcast will be available on the company’s website.
About Mondelēz International
Mondelēz International, Inc. (Nasdaq: MDLZ) empowers people to snack right in over 150 countries around the world. With 2023 net revenues of approximately $36 billion, MDLZ is leading the future of snacking with iconic global and local brands such as Oreo, Ritz, LU, Clif Bar and Tate’s Bake Shop biscuits and baked snacks, as well as Cadbury Dairy Milk, Milka and Toblerone chocolate. Mondelēz International is a proud member of the Standard and Poor’s 500, Nasdaq 100 and Dow Jones Sustainability Index. Visit www.mondelezinternational.com or follow the company on X at x.com/MDLZ.
| Contact: | Tracey Noe (Media) | Shep Dunlap (Investors) |
| +1 847 943 5678 | +1 847 943 5454 | |
| news@mdlz.com | ir@mdlz.com |
- Suominen has signed a credit facility agreement - July 3, 2025
- THEON receives a new order from a Northern European country for the thermal clip-on IRIS -C and swiftly converts soft backlog to hard backlog - July 3, 2025
- Oxford BioTherapeutics Announces Third Oncology Drug Candidate from Boehringer Ingelheim Collaboration Selected to Advance into IND-Enabling Studies - July 3, 2025
